Chiral recognition of dapoxetine enantiomers with methylated-gamma-cyclodextrin: A validated capillary electrophoresis method

Journal of Pharmaceutical and Biomedical Analysis

Volumn 62, Issue , 2012, Pages 42-47

  Neumajer, Gábor ^a   Sohajda, Tamás ^a,b   Darcsi, András ^a   Tóth, Gergo ^a   Szente, Lajos ^b   Noszál, Béla ^a   Béni, Szabolcs ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b CycloLab Cyclodextrin Research & Development Laboratory Ltd   (Hungary)

Author keywords

Enantioseparation; Orthogonal experimental design; Priligy; Synthesis; Validation

Indexed keywords

BUFFER; DAPOXETINE; GAMMA CYCLODEXTRIN; SILICON DIOXIDE;

ARTICLE; CAPILLARY ZONE ELECTROPHORESIS; CHEMICAL PARAMETERS; CHIRALITY; COMPLEX FORMATION; ELECTRIC POTENTIAL; ENANTIOMER; LIMIT OF DETECTION; LIMIT OF QUANTITATION; METHYLATION; PH; PRIORITY JOURNAL; TEMPERATURE; VALIDATION STUDY;

BENZYLAMINES; ELECTROPHORESIS, CAPILLARY; GAMMA-CYCLODEXTRINS; LIMIT OF DETECTION; MAGNETIC RESONANCE SPECTROSCOPY; METHYLATION; NAPHTHALENES; REPRODUCIBILITY OF RESULTS; STEREOISOMERISM;

EID: 84857140267     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2011.12.032     Document Type: Article

References (37)

1. Goldstein I. Premature to early ejaculation: a sampling of manuscripts regarding the most common male sexual dysfunction published in the IJIR: The Journal of Sexual Medicine. Int. J. Impot. Res. 2003, 15:307-308.
2. Kendirci M., Salem E., Hellstrom W.J.G. Dapoxetine, a novel selective serotonin transport inhibitor for the treatment of premature ejaculation. Ther. Clin. Risk Manage. 2007, 3:277-289.
3. Ahlenius S., Larsson K., Svensson L., Hjorth S., Carlsson A., Lindberg P., Wikstrom H., Sanchez D., Arvidsson L.E., Hacksell U., Nilsson J.I. Effects of a new type of 5-HT receptor agonist on male rat sexual behavior. Pharmacol. Biochem. Behav. 1981, 15:785-792.
4. Montague D.K., Jarow J., Broderick G.A., Dmochowski R.R., Heaton J.P., Lue T.F., Nehra A., Sharlip I.D. AUA guideline on the pharmacologic management of premature ejaculation. J. Urol. 2004, 172:190-194.
5. Modi N.B., Dresser M.J., Simon M., Lin D., Desai D., Gupta S. Single- and multiple dose pharmacokinetics of dapoxetine hydrochloride, a novel agent for the treatment of premature ejaculation. J. Clin. Pharmacol. 2006, 46:301-309.
6. 14C isotopomer. J. Label. Compd. Radiopharm. 1992, XXXI:305-315.
7. Sorbera L.A., Castaner J., Castaner R.M. Dapoxetine hydrochloride. Drugs Future 2004, 29:1201-1205.
8. Torre O., Gotor-Fernández V., Gotor V. Lipase-catalyzed resolution of chiral 1,3-amino alcohols: application in the asymmetric synthesis of (S)-dapoxetine. Tetrahedron 2006, 17:860-866.
9. Siddiqui S.A., Srinivasan K.V. Enantioselective synthesis of (S)-dapoxetine. Tetrahedron 2007, 18:2099-2103.
10. Venkatesan K., Srinivasan K.V. A stereoselective synthesis of (S)-dapoxetine starting from transcinnamyl alcohol. ARKIVOC 2008, XVI:302-310.
11. Chincholkar P.M., Kale A.S., Gumaste V.K., Deshmukh A.R.A.S An efficient formal synthesis of (S)-dapoxetine from enantiopure 3-hydroxy azetidin-2-one. Tetrahedron 2009, 65:2605-2609.
12. Rodríguez-Mata M., García-Urdiales E., Gotor-Fernández V., Gotor V. Stereoselective chemoenzymatic preparation of β-amino esters: molecular modelling considerations in lipase-mediated processes and application to the synthesis of (S)-dapoxetine. Adv. Synth. Catal. 2010, 352:395-406.
13. Kang S., Lee H-K. Highly efficient, enantioselective syntheses of (S)-(+)- and (R)-(-)-dapoxetine starting with 3-phenyl-1-propanol. J. Org. Chem. 2010, 75:237-240.
14. Liu K.K-C., Sakya S.M., O'Donnell C.J., Flick A.C., Li J. Synthetic approaches to the 2009 new drugs. Bioorg. Med. Chem. 2011, 19:1136-1154.
15. D.W. Robertson, D.T., Wong, D.C. Thompson, U.S. Patent 5 135 947 (1992).
16. Li L., Lowa M-Y., Geb X., Bloodworth B.C., Koha H-L. Isolation and structural elucidation of dapoxetine as an adulterant in a health supplement used for sexual performance enhancement. J. Pharm. Biomed. Anal. 2009, 50:724-728.
17. Kuhnl R., Hoffstetter-Kuhn S. Chiral separation by capillary electrophoresis. Chromatographia 1992, 34:505-512.
18. Chankvetadze B. Capillary Electrophoresis in Chiral Analysis 1997, Wiley, Chichester.
19. Deeb S.E., Hasemann P., Wätzig H. Strategies in method development to quantify enantiomeric impurities using CE. Electrophoresis 2008, 29:3552-3562.
20. Fanali S., Furlanetto S., Aturki Z., Pinzauti S. Experimental design methodologies to optimize the CE separation of epinephrine enantiomers. Chromatographia 1998, 48:395-401.
21. He Y., Kee Lee H. Orthogonal array design experiments for optimizing the separation of various pesticides by cyclodextrin-modified micellar electrokinetic chromatography. J. Chromatogr. A 1998, 793:331-340.
22. Liu M., Zheng Y., Ji Y., Zhang C. Development and validation of a capillary electrophoresis method for the enantiomeric purity determination of RS86017 using experimental design. J. Pharm. Biomed. Anal. 2011, 55:93-100.
23. Piperaki S., Parissi-Poulou M. Use of cyclodextrins as chiral selectors for direct resolution of the enantiomers of fluoxetine and its metabolite norfluoxetine by HPLC. Chirality 1993, 5:258-266.
24. Piperaki S., Penn S.G., Goodall D.M. Systematic approach to treatment of enantiomeric separations in capillary electrophoresis and liquid chromatography II. A study of the enantiomeric separation of fluoxetine and norfluoxetine. J. Chromatogr. A 1995, 700:59-67.
25. Desiderio C., Rudaz S., Raggi M.A., Fanali S. Enantiomeric separation of fluoxetine and norfluoxetine in plasma and serum samples with high detection sensitivity capillary electrophoresis. Electrophoresis 1999, 20:3432-3438.
26. Chen D., Jiang S., Chen Y., Hu Y. HPLC determination of sertraline in bulk drug, tablets and capsules using hydroxypropyl-beta-cyclodextrin as mobile phase additive. J. Pharm. Biomed. Anal. 2004, 34:239-245.
27. Rao R.N., Talluri M.V.N.K., Maurya P.K. Separation of stereoisomers of sertraline and its related enantiomeric impurities on a dimethylated beta-cyclodextrin stationary phase by HPLC. J. Pharm. Biomed. Anal. 2009, 50:281-286.
28. Bernini A., Spiga O., Ciutti A., Scarselli M., Bottoni G., Mascagni P., Niccolai N. NMR studies of the inclusion complex between β-cyclodextrin and paroxetine. Eur. J. Pharm. Sci. 2004, 22:445-450.
29. Lu T., Yang M. Separation of paroxetine and its intermediate enantiomers by high performance liquid chromatography using carboxy-methyl-β-cyclodextrin as chiral mobile phase additive. Chin. J. Chromatogr. 2007, 25:830-833.
30. Inoue T., Chang J.P. Chiral separation of fluoxetine and its analogs with charged cyclodextrins by capillary electrophoresis. J. Liq. Chromatogr. Relat. Technol. 2003, 26:2351-2367.
31. Rudaz S., Calleri E., Geiser L., Cherkaoui S., Prat J., Veuthey J-L. Infinite enantiomeric resolution of basic compounds using highly sulfated cyclodextrin as chiral selector in capillary electrophoresis. Electrophoresis 2003, 24:2633-2641.
32. Andersson K-E., Mulhall J.P., Wyllie M.G. Pharmacokinetic and pharmacodynamic features of dapoxetine, a novel drug for 'on demand' treatment of premature ejaculation. B. J. U. Int. 2005, 97:311-315.
33. Rundlett K.L., Armstrong D.W. Examination of the origin, variation, and proper use of expressions for the estimation of association constants by capillary electrophoresis. J. Chromatogr. A 1996, 721:173-186.
34. Fanali S. Use of cyclodextrins in capillary zone electrophoresis: resolution of terbutaline and propranolol enantiomers. J. Chromatogr. 1991, 545:437-444.
35. Guideline Q2 (R1), validation of analytical procedures: text and methodology. International Conference on Harmonization 2005, http://www.ich.org/.
36. Jimidar M., Niemeijer N., Peeters R., Hoogmartens J. Robustness testing of a liquid chromatography method for the determination of vorozole and its related compounds in oral tablets. J. Pharm. Biomed. Anal. 1998, 18:479-485.
37. Heyden Y.V., Nijhuis A., Smeyers-Verbeke J., Vandeginste B.G.M., Massart D.L. Guidance for robustness/ruggedness tests in method validation. J. Pharm. Biomed. Anal. 2001, 24:723-753.